Lipid A Lipopolysaccharide for CDH Lung and Diaphragm Repair
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is no established treatment for Congenital Diaphragmatic Hernia (CDH), a condition where the diaphragm does not develop properly, leading to severe lung and heart abnormalities, and current diagnostic methods are unreliable and labor-intensive, with fetal interventions like fetoscopy endoluminal tracheal occlusion (FETO) being risky and experimental.
Innovation Solution
A lipopolysaccharide characterized by specific lipid A composition is used to induce macrophage polarization towards an M2 phenotype, promoting tissue repair and lung differentiation, administered via subcutaneous, subdermal, intramuscular, or intravenous injection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If fetoscopy endoluminal tracheal occlusion (FETO) is performed to treat CDH, then lung development may be improved, but the procedure carries high risk and is experimental
Solution Approach 1:
The patent uses lipopolysaccharide as an intermediary substance to modulate the immune response and promote lung development indirectly, avoiding the direct mechanical intervention of FETO. The LPS acts as a mediator that stimulates macrophage polarization and tissue repair without requiring invasive fetal procedures
Solution Approach 2:
The patent replaces the mechanical surgical intervention of FETO with a biochemical approach using lipopolysaccharide administration. Instead of mechanically occluding the trachea to stimulate lung growth, the invention uses chemical signaling through LPS to achieve similar therapeutic effects through immune system modulation
2Measurement precision
If current diagnostic methods are used for CDH, then diagnosis can be obtained, but the methods are unreliable and labor-intensive
Solution Approach 1:
The patent enables the fetal immune system to self-diagnose and self-correct the condition through lipopolysaccharide administration. The endogenous macrophage response serves as both diagnostic indicator and therapeutic mechanism, eliminating the need for external diagnostic procedures and intervention
3Reliability
If lipopolysaccharide is used to induce macrophage polarization towards M2 phenotype, then tissue repair and lung differentiation are promoted, but the mechanism is complex involving multiple signaling pathways
Solution Approach 1:
The lipopolysaccharide serves as a simple intermediary molecule that triggers a cascade of biological responses. Rather than directly activating multiple complex pathways, the LPS acts as a primary signal that the fetal immune system processes through its natural macrophage polarization mechanisms, simplifying the intervention while maintaining therapeutic effectiveness
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The lipopolysaccharide effectively reduces the incidence and severity of CDH in animal models by enhancing lung development and diaphragm repair, offering a safer and more effective therapeutic strategy than existing interventions.
Implementation Method 1
The LPS of the invention acts as dual TLR2/4 ligands
Data Source
AI summary
The present invention refers to lipopolysaccharides, characterized by comprising: a) O-specific polysaccharide antigen consisting of one or more repeating units, b) core oligosaccharide, and c) lipid A, wherein the lipid A is characterized in that it comprises at least 6 fatty acids and wherein at least one of the fatty acids has a chain comprising at least 24 carbon atoms, optionally with or without other substitutions, for use as a medicament.